Cytosolix is a private, early stage life sciences company spun out of Yale University, developing novel oral & IV derivatives of known small molecule oncology drugs that selectively target cancer cells via a universal biomarker of solid tumors - acidity.
Location: United States, Connecticut, Tolland
Employees: 1-10
Total raised: $230K
Investors 4
| Date | Name | Website |
| - | Connecticu... | ctinnovati... |
| 08.07.2022 | Creative D... | creativede... |
| - | FirstXFoun... | firstxfoun... |
| - | Endless Fr... | endlessfro... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.06.2019 | - | $230K | - |
Mentions in press and media 1
| Date | Title | Description |
| - | Cytosolix | “Cytosolix Homepage” |